The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Addiction and Brain Reward and Antireward Pathways
Open accessAbstract
Addictive drugs have in common that they are voluntarily self-administered by laboratory animals (usually avidly), and that they enhance the functioning of the reward circuitry of the brain (producing the 'high' that the drug user seeks). The core reward circuitry consists of an 'in-series' circuit linking the ventral tegmental area, nucleus accumbens and ventral pallidum via the medial forebrain bundle. Although originally believed to simply encode the set point of hedonic tone, these circuits are now believed to be functionally far more complex, also encoding attention, expectancy of reward, disconfirmation of reward expectancy, and incentive motivation. 'Hedonic dysregulation' within these circuits may lead to addiction. The 'second-stage' dopaminergic component in this reward circuitry is the crucial addictive-drug-sensitive component. All addictive drugs have in common that they enhance (directly or indirectly or even transsynaptically) dop-aminergic reward synaptic function in the nucleus accumbens. Drug self-administration is regulated by nucleus accumbens dopamine levels, and is done to keep nucleus accumbens dopamine within a specific elevated range (to maintain a desired hedonic level). For some classes of addictive drugs (e.g. opiates), tolerance to the euphoric effects develops with chronic use. Postuse dysphoria then comes to dominate reward circuit hedonic tone, and addicts no longer use drugs to get high, but simply to get back to normal ('get straight'). The brain circuits mediating the pleasurable effects of addictive drugs are anatomically, neurophysiologically and neurochemically different from those mediating physical dependence, and from those mediating craving and relapse. There are important genetic variations in vulnerability to drug addiction, yet environmental factors such as stress and social defeat also alter brain-reward mechanisms in such a manner as to impart vulnerability to addiction. In short, the 'bio-psycho-social' model of etiology holds very well for addiction. Addiction appears to correlate with a hypodopaminergic dysfunctional state within the reward circuitry of the brain. Neuroimaging studies in humans add credence to this hypothesis. Credible evidence also implicates serotonergic, opioid, endocannabinoid, GABAergic and glutamatergic mechanisms in addiction. Critically, drug addiction progresses from occasional recreational use to impulsive use to habitual compulsive use. This correlates with a progression from reward-driven to habit-driven drug-seeking behavior. This behavioral progression correlates with a neuroanatomical progression from ventral striatal (nucleus accumbens) to dorsal striatal control over drug-seeking behavior. The three classical sets of craving and relapse triggers are (a) reexposure to addictive drugs, (b) stress, and (c) reexposure to environmental cues (people, places, things) previously associated with drug-taking behavior. Drug-triggered relapse involves the nucleus accumbens and the neurotransmitter dopamine. Stress-triggered relapse involves (a) the central nucleus of the amygdala, the bed nucleus of the stria terminalis, and the neurotransmitter corticotrophin-releasing factor, and (b) the lateral tegmental noradrenergic nuclei of the brain stem and the neurotransmitter norepinephrine. Cue-triggered relapse involves the basolateral nucleus of the amygdala, the hippocampus and the neurotransmitter glutamate. Knowledge of the neuroanatomy, neurophysiology, neurochemistry and neuropharmacology of addictive drug action in the brain is currently producing a variety of strategies for pharmacotherapeutic treatment of drug addiction, some of which appear promising.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–256 of 256
Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds
Nazzaro, J. M., Seeger, T., & Gardner, E. L. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90398-1 · Cited by 79
Self-citationTanda, G., Newman, A. H., & Katz, J. L. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57007-4 · Cited by 78
Hypothesis-Driven Medication Discovery for the Treatment of Psychostimulant Addiction
Xi, Z., & Gardner, E. L. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801030303 · Cited by 78
Self-citationHeidbreder, C. A., Andreoli, M., Marcon, C., Hutcheson, D. M., Gardner, E. L., & Ashby, C. R. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00051.x · Cited by 78
Self-citationSpiller, K. J., Xi, Z., Peng, X., Newman, A. H., Ashby, C. R., Heidbreder, C. A., Gaál, J., & Gardner, E. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0986-6 · Cited by 77
Self-citationGinovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199902)31:2<154::aid-syn9>3.0.co;2-k · Cited by 76
Li, X., Li, J., Peng, X., Spiller, K. J., Gardner, E. L., & Xi, Z. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.236 · Cited by 75
Self-citationGlutamate: The New Frontier in Pharmacotherapy for Cocaine Addiction
Uys, J. D. K., & LaLumiere, R. T. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927868 · Cited by 75
Ozaki, S., Narita, M., Narita, M., Ozaki, M., Khotib, J., & Suzuki, T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02272.x · Cited by 74
Li, X., Li, J., Gardner, E. L., & Xi, Z. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06851.x · Cited by 74
Self-citationBrodie, J. D., Case, B. G., Figueroa, E., Dewey, S. L., Robinson, J. A., WANDERLING, J. A., & LASKA, E. M. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121811 · Cited by 73
Li, X., Hoffman, A. F., Peng, X.-Q., Lupica, C., Gardner, E., & Xi, Z.-X. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1432-0 · Cited by 72
Self-citationGamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds
Kushner, S. A., Dewey, S. L., & Kornetsky, C. H. (1997) · Psychopharmacology · doi:10.1007/s002130050418 · Cited by 71
Hayes, R. J., Vorel, S. R., Spector, J. A., Liu, X., & Gardner, E. L. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1328-3 · Cited by 68
Self-citationFitting intracranial self-stimulation data with growth models.
Coulombe, D., & Miliaressis, E. (1987) · Behavioral Neuroscience · doi:10.1037//0735-7044.101.2.209 · Cited by 67
Narcotic blockade--a medical technique for stopping heroin use by addicts.
Dole, V. P., Nyswander, M. E., & Kreek, M. J. (1966) · PubMed · Cited by 65
Pharmacotherapy of Addictive Disorders
Ross, S., & Peselow, E. D. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181a91655 · Cited by 65
Morphine fails to produce tolerance when administered in the presence of formalin pain in rats
Vaccarino, A. L., Marek, P., Kest, B., Ben‐Eliyahu, S., Couret, L. C., Kao, B., & Liebeskind, J. C. (1993) · Brain Research · doi:10.1016/0006-8993(93)90332-h · Cited by 63
Xi, Z., Li, X., Peng, X., Li, J., Chun, L. E., Gardner, E. L., Thomas, A. G., Slusher, B. S., & Ashby, C. R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06478.x · Cited by 62
Self-citationBrodkin, E. S., Carlezon, W. A., Haile, C. N., Kosten, T. A., Heninger, G. R., & Nestler, E. J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00663-5 · Cited by 62
Li, X., Gardner, E. L., & Xi, Z. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.11.005 · Cited by 60
Self-citationSpiller, K., Xi, Z.-X., Li, X., Ashby, C. R., Callahan, P. M., Tehim, A., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.04.006 · Cited by 58
Self-citationRedolat, R., Pérez‐Martinez, A., Carrasco, M., & Mesa, P. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030230 · Cited by 58
Gardner, E. L. (1999) · Cited by 57
Self-citationDrug craving and positive/negative hedonic brain substrates activated by addicting drugs
Gardner, E. L., & Lowinson, J. H. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80044-2 · Cited by 56
Self-citationGABA Modulation of Cocaine Self‐Administration
Roberts, D. C. S., & Brebner, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06680.x · Cited by 54
Xi, Z., Kiyatkin, M. E., Li, X., Peng, X., Wiggins, A., Spiller, K. J., Li, J., & Gardner, E. L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.016 · Cited by 51
Self-citationThe neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence
Mason, B. J., & Heyser, C. J. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903512943 · Cited by 51
Disruption of the CRF2 Receptor Pathway Decreases the Somatic Expression of Opiate Withdrawal
Papaleo, F., Ghozland, S. G., Ingallinesi, M., Roberts, A. J., Koob, G. F., & Contarino, A. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.8 · Cited by 48
Pharmacogenetics of Drug Dependence: Role of Gene Variations in Susceptibility and Treatment
Khokhar, J. Y., Ferguson, C. S., Zhu, A. Z. X., & Tyndale, R. F. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105826 · Cited by 48
Peoples, L. L., & Cavanaugh, D. J. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00849.2002 · Cited by 47
Attention deficit hyperactivity disorder (ADHD) and substance use disorders
Wilson, J. J., & Levin, F. R. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0044-8 · Cited by 45
Mechanism-based medication development for the treatment of nicotine dependence
Xi, Z., Spiller, K. J., & Gardner, E. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.46 · Cited by 44
Self-citationGinovart, N., Wilson, A. A., Houle, S., & Kapur, S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.019 · Cited by 41
Rademacher, D. J., Rosenkranz, J. A., Morshedi, M. M., Sullivan, E. M., & Meredith, G. E. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.6165-09.2010 · Cited by 39
Gardner, E. L., Schiffer, W. K., Horan, B., Highfield, D. A., Dewey, S. L., Brodie, J. D., & Ashby, C. R. (2002) · Synapse · doi:10.1002/syn.10138 · Cited by 39
Self-citationOverview of chemical sampling techniques
Gardner, E. L., Chen, J., & Paredes, W. M. (1993) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(93)90091-5 · Cited by 37
Self-citationYamamoto, T., Anggadiredja, K., & Hiranita, T. (2004) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fmj04003x5 · Cited by 36
Peng, X., Xi, Z., Li, X., Spiller, K. J., Li, J., Chun, L. E., Wu, K.-M., Froimowitz, M., & Gardner, E. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.133 · Cited by 35
Self-citationLee, R., Criado, J. R., Koob, G. F., & Henriksen, S. J. (1999) · Synapse · Cited by 33
Self-stimulation pathways in the monkey, Macaca mulatta
Routtenberg, A., Gardner, E. L., & Huang, Y. H. (1971) · Experimental Neurology · doi:10.1016/0014-4886(71)90115-4 · Cited by 31
Self-citationPeng, X., Li, X., Gilbert, J. G., Pak, A. C., Ashby, C. R., Brodie, J. D., Dewey, S. L., Gardner, E. L., & Xi, Z. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.10.004 · Cited by 28
Self-citationPeng, X., Li, J., Gardner, E. L., Ashby, C. R., Thomas, A. G., Wozniak, K. M., Slusher, B. S., & Xi, Z. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.062 · Cited by 28
Self-citationPaul, M., Dewey, S. L., Gardner, E. L., Brodie, J. D., & Ashby, C. R. (2001) · Synapse · doi:10.1002/syn.1078 · Cited by 28
Self-citationBehavioral Changes During Intracerebral Electrical Stimulation
Higgins, J. W. (1956) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1956.02330280057006 · Cited by 27
Ablation of the Central Noradrenergic Neurons for Unraveling Their Roles in Stress and Anxiety
Itoi, K. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.012 · Cited by 24
Peoples, L. L., Uzwiak, A. J., Gee, F., Fabbricatore, A. T., Muccino, K. J., MOHTA, B. D., & West, M. O. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09322.x · Cited by 23
Recent Experiments Testing an Opponent-Process Theory of Acquired Motivation
Solomon, R. L. (1980) · Springer eBooks · doi:10.1007/978-94-009-8225-3_18 · Cited by 22
Hasenöhrl, R. U., Frisch, C., & Huston, J. P. (1998) · Neuroreport · doi:10.1097/00001756-199801050-00002 · Cited by 18
Attention Deficit Hyperactivity Disorder and Substance Use Disorders
Wilens, T. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.12.2059 · Cited by 16
Gardner, E. L., Liu, X., Paredes, W. M., Giordano, A. L., Spector, J. A., Lepore, M., Wu, K.-M., & Froimowitz, M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.009 · Cited by 16
Self-citationUse of animal models to develop antiaddiction medications
Gardner, E. L. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0061-y · Cited by 13
Self-citationWise, R. A. (1993) · Seminars in Neuroscience · doi:10.1016/s1044-5765(05)80041-7 · Cited by 12
Update on smoking cessation therapies
Glynn, D. A., Cryan, J. F., Kent, P., Flynn, R. A., & Kennedy, M. P. (2009) · Advances in Therapy · doi:10.1007/s12325-009-0022-9 · Cited by 12
Gardner, E. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-36391-8_4 · Cited by 7
Self-citationKishore, K., & Desiraju, T. (1990) · PubMed · Cited by 3
Cited by
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Exercise as a novel treatment for drug addiction: A neurobiological and stage-dependent hypothesis
Lynch, W. J., Peterson, A. B., Sanchez, V., Abel, J., & Smith, M. A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.06.011 · Cited by 376
Psychological processing in chronic pain: a neural systems approach
Simons, L. E., Elman, I., & Borsook, D. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.006 · Cited by 359
Mindfulness-Based Relapse Prevention for substance craving
Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.04.001 · Cited by 337
Common brain mechanisms of chronic pain and addiction
Elman, I., & Borsook, D. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.027 · Cited by 303
Metadata
- Authors
- Gardner, E. L.
- Venue
- Advances in Psychosomatic Medicine
- Publisher
- S. Karger AG
- Published
- 2011
- Volume
- 30
- Pages
- 22-60
- ISSN
- 0065-3268 (ISSN-L)
- 1662-2855
- OpenAlex
- W1561492980
- Cited by
- 417
- References
- 256
- FWCI
- 27.66
- Type
- book chapter
- Language
- en
- Open access
- green
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.